Plant Natural Products for Human Health
Plants have served mankind as an important source of foods and medicines. While we all consume plants and their products for nutritional support, a majority of the world population also rely on botanical remedies to meet their health needs, either as their own "traditional medicine" or as...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Book Chapter |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2019
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 07596naaaa2202233uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_56345 | ||
| 005 | 20210211 | ||
| 020 | |a books978-3-03897-713-1 | ||
| 020 | |a 9783038977124 | ||
| 024 | 7 | |a 10.3390/books978-3-03897-713-1 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 100 | 1 | |a Zhang, Hongjie |4 auth | |
| 700 | 1 | |a Che, Chun-Tao |4 auth | |
| 245 | 1 | 0 | |a Plant Natural Products for Human Health |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2019 | ||
| 300 | |a 1 electronic resource (514 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Plants have served mankind as an important source of foods and medicines. While we all consume plants and their products for nutritional support, a majority of the world population also rely on botanical remedies to meet their health needs, either as their own "traditional medicine" or as "complementary and alternative medicine". From a pharmaceutical point of view, many compounds obtained from plant sources have long been known to possess bio/pharmacological activities, and historically, plants have yielded many important drugs for human use, from morphine discovered in the early nineteenth century to the more recent paclitaxel and artemisinin. Today, we are witnessing a global resurgence in interest and use of plant-based therapies and botanical products, and natural products remain an important and viable source of lead compounds in many drug discovery programs.This Special Issue on "Plant Natural Products for Human Health" compiles a series of scientific reports to demonstrate the medicinal potentials of plant natural products. It covers a range of disease targets, such as diabetes, inflammation, cancer, neurological disease, cardiovascular disease, liver damage, bacterial, and fungus infection and malarial. These papers provide important insights into the current state of research on drug discovery and new techniques. It is hoped that this Special Issue will serve as a timely reference for researchers and scholars who are interested in the discovery of potentially useful molecules from plant sources for health-related applications. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 653 | |a PhGs | ||
| 653 | |a bitter orange | ||
| 653 | |a immunomodulator | ||
| 653 | |a A549 cells | ||
| 653 | |a bergapten | ||
| 653 | |a triptolide | ||
| 653 | |a BMP/Smad | ||
| 653 | |a phytochemicals | ||
| 653 | |a antioxidant enzymes | ||
| 653 | |a kumquat | ||
| 653 | |a MTT assay | ||
| 653 | |a HepaRG cells | ||
| 653 | |a human health | ||
| 653 | |a nanoparticles | ||
| 653 | |a dendritic cells | ||
| 653 | |a drug discovery | ||
| 653 | |a biofilm | ||
| 653 | |a catechin | ||
| 653 | |a antitubercular activity | ||
| 653 | |a Panax notoginseng saponins | ||
| 653 | |a animals | ||
| 653 | |a mouse-hair growth | ||
| 653 | |a A? | ||
| 653 | |a curcumin | ||
| 653 | |a WNT/?-catenin | ||
| 653 | |a copaiba | ||
| 653 | |a AD | ||
| 653 | |a Plasmodium parasites | ||
| 653 | |a traditional medicine | ||
| 653 | |a procyanidin A2 | ||
| 653 | |a PET inhibition | ||
| 653 | |a rheumatoid arthritis | ||
| 653 | |a cannabinoid type 1 receptor | ||
| 653 | |a iridoids | ||
| 653 | |a inflammatory bowel disease | ||
| 653 | |a acute liver injury | ||
| 653 | |a human-hair-follicle dermal papilla cells | ||
| 653 | |a Neuroprotective | ||
| 653 | |a dihydromyricetin | ||
| 653 | |a AMPK | ||
| 653 | |a thromboembolism | ||
| 653 | |a ginseng | ||
| 653 | |a drug design and development | ||
| 653 | |a endoplasmic reticulum stress | ||
| 653 | |a mitogen-activated protein kinase | ||
| 653 | |a Nrf2 | ||
| 653 | |a prenylated flavonoids | ||
| 653 | |a inflammation | ||
| 653 | |a preclinical studies | ||
| 653 | |a plants | ||
| 653 | |a dietary supplements | ||
| 653 | |a Glycyrrhiza uralensis | ||
| 653 | |a aspirin | ||
| 653 | |a Tripterygium wilfordii | ||
| 653 | |a P. eryngii | ||
| 653 | |a reperfusion | ||
| 653 | |a ethnopharmacology | ||
| 653 | |a glucans | ||
| 653 | |a innovation | ||
| 653 | |a hpatoprotection | ||
| 653 | |a hinokitiol | ||
| 653 | |a phytocannabinoid | ||
| 653 | |a antistaphylococcal activity | ||
| 653 | |a Shh/Gli | ||
| 653 | |a green tea | ||
| 653 | |a sesquiterpenoids | ||
| 653 | |a adjuvant-induced arthritis | ||
| 653 | |a yuzu | ||
| 653 | |a hepatotoxicity | ||
| 653 | |a p53/Bax | ||
| 653 | |a Keap1 | ||
| 653 | |a nuclear factor-kappaB | ||
| 653 | |a oxidative stress | ||
| 653 | |a pharmacokinetic study | ||
| 653 | |a cinnamamides | ||
| 653 | |a toxicity | ||
| 653 | |a APAP | ||
| 653 | |a Astragali Radix | ||
| 653 | |a computational softwares | ||
| 653 | |a plant natural product | ||
| 653 | |a onion | ||
| 653 | |a anti-malaria activity | ||
| 653 | |a lipogenesis | ||
| 653 | |a bleeding time | ||
| 653 | |a diterpenoids | ||
| 653 | |a Penthorum chinense Pursh | ||
| 653 | |a myocardial hypertrophy | ||
| 653 | |a automation | ||
| 653 | |a adjuvant | ||
| 653 | |a grapefruit | ||
| 653 | |a melanoma cell | ||
| 653 | |a essential oil | ||
| 653 | |a sweet orange | ||
| 653 | |a Amadori rearrangement compounds | ||
| 653 | |a heme oxygenase | ||
| 653 | |a global health | ||
| 653 | |a calorie restriction | ||
| 653 | |a bergamot | ||
| 653 | |a liposomes | ||
| 653 | |a EGCG | ||
| 653 | |a celastrol | ||
| 653 | |a herb-drug interactions | ||
| 653 | |a cannabigerol | ||
| 653 | |a anti-inflammation | ||
| 653 | |a OH· free radical | ||
| 653 | |a molecular targets | ||
| 653 | |a gluconeogenesis | ||
| 653 | |a microbiome | ||
| 653 | |a SIRT1 | ||
| 653 | |a fucoidan | ||
| 653 | |a heart | ||
| 653 | |a PC12 cells | ||
| 653 | |a acetaminophen | ||
| 653 | |a omics | ||
| 653 | |a time-kill assay | ||
| 653 | |a arthritis | ||
| 653 | |a lychee seed | ||
| 653 | |a bioinformatics | ||
| 653 | |a structure-activity relationship | ||
| 653 | |a precision medicine | ||
| 653 | |a orange petitgrain | ||
| 653 | |a immune modulation | ||
| 653 | |a antiproliferation | ||
| 653 | |a flavonoids | ||
| 653 | |a scoulerine | ||
| 653 | |a oleoresin | ||
| 653 | |a triterpenic acids | ||
| 653 | |a Cannabis sativa | ||
| 653 | |a NAFLD | ||
| 653 | |a biological activity | ||
| 653 | |a differentiation | ||
| 653 | |a oxygen consumption rate | ||
| 653 | |a mitochondrial bioenergetics | ||
| 653 | |a neroli | ||
| 653 | |a apoptosis | ||
| 653 | |a targeted delivery | ||
| 653 | |a platelet activation | ||
| 653 | |a protein kinase | ||
| 653 | |a heat-process | ||
| 653 | |a hepatic steatosis | ||
| 653 | |a hyperglycemia | ||
| 653 | |a natural products | ||
| 653 | |a lemon | ||
| 653 | |a genistein | ||
| 653 | |a neuroinflammation | ||
| 653 | |a astragaloside IV | ||
| 653 | |a cytoxicity | ||
| 653 | |a flavonoid | ||
| 653 | |a paracetamol | ||
| 653 | |a medicinal plants | ||
| 653 | |a insulin resistance | ||
| 653 | |a resveratrol | ||
| 653 | |a mandarin | ||
| 653 | |a garlic | ||
| 653 | |a TGF-? | ||
| 653 | |a morin hydrate | ||
| 653 | |a sirtuin 3 | ||
| 653 | |a MMPs | ||
| 653 | |a gomisin N | ||
| 653 | |a lime | ||
| 653 | |a Ziziphus jujuba | ||
| 653 | |a antifungal activity | ||
| 653 | |a ischemia | ||
| 653 | |a migration | ||
| 653 | |a caspases | ||
| 653 | |a small molecules | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/1178 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/56345 |7 0 |z DOAB: description of the publication |